708 related articles for article (PubMed ID: 15817521)
1. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
[TBL] [Abstract][Full Text] [Related]
2. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent.
Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S
Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.
Yan Q; Zhang J; Liu H; Babu-Khan S; Vassar R; Biere AL; Citron M; Landreth G
J Neurosci; 2003 Aug; 23(20):7504-9. PubMed ID: 12930788
[TBL] [Abstract][Full Text] [Related]
4. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
[TBL] [Abstract][Full Text] [Related]
5. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
Gasparini L; Ongini E; Wenk G
J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
[TBL] [Abstract][Full Text] [Related]
6. Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells.
Blasko I; Apochal A; Boeck G; Hartmann T; Grubeck-Loebenstein B; Ransmayr G
Neurobiol Dis; 2001 Dec; 8(6):1094-101. PubMed ID: 11741404
[TBL] [Abstract][Full Text] [Related]
7. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
van Groen T; Miettinen P; Kadish I
J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma.
Sastre M; Dewachter I; Rossner S; Bogdanovic N; Rosen E; Borghgraef P; Evert BO; Dumitrescu-Ozimek L; Thal DR; Landreth G; Walter J; Klockgether T; van Leuven F; Heneka MT
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):443-8. PubMed ID: 16407166
[TBL] [Abstract][Full Text] [Related]
10. Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen.
Bernardo A; Ajmone-Cat MA; Gasparini L; Ongini E; Minghetti L
J Neurochem; 2005 Feb; 92(4):895-903. PubMed ID: 15686492
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice.
Cho JY; Kim HS; Kim DH; Yan JJ; Suh HW; Song DK
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):901-7. PubMed ID: 15970368
[TBL] [Abstract][Full Text] [Related]
12. PPARgamma agonist curcumin reduces the amyloid-beta-stimulated inflammatory responses in primary astrocytes.
Wang HM; Zhao YX; Zhang S; Liu GD; Kang WY; Tang HD; Ding JQ; Chen SD
J Alzheimers Dis; 2010; 20(4):1189-99. PubMed ID: 20413894
[TBL] [Abstract][Full Text] [Related]
13. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.
van Groen T; Kadish I
Brain Res Brain Res Rev; 2005 Apr; 48(2):370-8. PubMed ID: 15850676
[TBL] [Abstract][Full Text] [Related]
14. Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA.
Melton LM; Keith AB; Davis S; Oakley AE; Edwardson JA; Morris CM
Glia; 2003 Oct; 44(1):1-12. PubMed ID: 12951652
[TBL] [Abstract][Full Text] [Related]
15. Effects of memantine on soluble Alphabeta(25-35)-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions.
Arif M; Chikuma T; Ahmed MM; Nakazato M; Smith MA; Kato T
Neuroscience; 2009 Dec; 164(3):1199-209. PubMed ID: 19733635
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice.
Rodrigo J; Fernández-Vizarra P; Castro-Blanco S; Bentura ML; Nieto M; Gómez-Isla T; Martínez-Murillo R; MartInez A; Serrano J; Fernández AP
Neuroscience; 2004; 128(1):73-89. PubMed ID: 15450355
[TBL] [Abstract][Full Text] [Related]
17. NOS-mediated morphological and molecular modifications in rats infused with Aβ (1-40), as a model of Alzheimer's disease, in response to a new lipophilic molecular combination codrug-1.
Zara S; Di Stefano A; Nasuti C; Rapino M; Patruno A; Pesce M; Sozio P; Cerasa LS; Cataldi A
Exp Gerontol; 2011 Apr; 46(4):273-81. PubMed ID: 21070848
[TBL] [Abstract][Full Text] [Related]
18. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
19. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
Toledo EM; Inestrosa NC
Mol Psychiatry; 2010 Mar; 15(3):272-85, 228. PubMed ID: 19621015
[TBL] [Abstract][Full Text] [Related]
20. Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease.
Damjanac M; Rioux Bilan A; Barrier L; Pontcharraud R; Anne C; Hugon J; Page G
Brain Res; 2007 Jan; 1128(1):40-9. PubMed ID: 17125750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
